Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimens.

نویسندگان

  • Po-Chu Lee
  • Chih-Yuan Lee
  • Rey-Heng Hu
  • Chiao Lo
  • Meng-Kun Tsai
  • Po-Huang Lee
چکیده

BACKGROUND Use of a calcineurin inhibitor (CNI) immunosuppressant following kidney transplantation is associated with development of vasomotor nephrotoxicity. This study was undertaken to evaluate and compare the influences of CNI-based and CNI-free immunosuppressant regimens on two intrarenal vascular resistance parameters, the resistive index (RI) and the pulsatility index (PI), in renal transplant recipients. METHODS Forty-nine renal transplant patients who received ultrasonography examination between January 2007 and December 2007 were enrolled in this case-control study. Thirty-one subjects received a CNI-based regimen, and 18 received a CNI-free (sirolimus-based) regimen. RI and PI were determined by duplex Doppler ultrasonography. RESULTS Patients receiving a CNI displayed lower cholesterol and triglyceride values and higher RI (mean: 0.7 vs. 0.6, P = 0.002) and PI values (mean: 1.3 vs. 1.1, P = 0.034). Multivariate analyses revealed that advanced age and use of alpha-blockers or diuretics were modestly associated with higher RI and PI values. By multivariate analysis, use of sirolimus was associated with a lower RI by -0.05 [95% confidence interval (CI): -0.085, -0.019; P = 0.003] but not with a lower PI (95% CI: -0.245, 0.001; P = 0.053). CONCLUSIONS Use of sirolimus is only modestly correlated with a reduced RI and is not associated with a reduced PI. These observations question the superiority of CNI-free over CNI-based regimens with regard to reduction of intrarenal vascular resistance post-transplantation. These findings combined with those regarding recipient factors also cast doubt on the specificity of intrarenal resistance indices for predicting allograft function and/or survival.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Therapeutic Drug Monitoring of Sirolimus,Correlation With Laboratory Parameters In Transplant Patients

Sirolimus is a potent immunosuppressive agent administered as prophylactic agent to prevent rejection after organ transplantation. Sirolimus must be used within a narrow therapeutic window. Due to inter- and intra-variability, sirolimus blood concentrations may be affected, therefore, there is no possibility of predicting the sirolimus blood concentrations based on the dose patients received. T...

متن کامل

اثر سیرولیموس در کاهش هیپرتروفی بطن چپ در گیرندگان کلیه پیوندی: کارآزمایی بالینی

Background: Persistence of left ventricular hypertrophy (LVH) in renal transplant recipients is associated with unfavorable outcomes. Calcineurin-inhibitor (CNI) nephrotoxicity is a major cause of morbidity and mortality after kidney transplantation. In this study we compared sirolimus (SRL) with calcineurin-inhibitor as primary immunosuppressants for the attenuation of left ventricular hypertr...

متن کامل

Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation.

Calcineurin-inhibitor-sparing strategies in kidney transplantation may spare patients the adverse effects of these drugs, but the efficacy of these strategies is unknown. Here, we conduct a meta-analysis to assess outcomes associated with reducing calcineurin inhibitor exposure from the time of transplantation. We search Medline, Embase, and Cochrane Register of Controlled Trials for randomized...

متن کامل

Bone morphogenic protein-7 and the kidney: current concepts and open questions.

version from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients. ATC Seattle 2005 28. Saurina A, Campistol JM, Piera C et al. Conversion form calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular hemodynamics and proteinuria. Nephrol Dial Transpl; in press 29. Fervenza FC, Fitzpatrick PM, Mertz J...

متن کامل

Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation.

After renal transplantation, immunosuppressive regimens associated with high short-term survival rates are not necessarily associated with high long-term survival rates, suggesting that regimens may need to be optimized over time. Calcineurin inhibitor (CNI) withdrawal from a sirolimus-based immunosuppressive regimen may maximize the likelihood of long-term graft and patient survival by minimiz...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

دوره 25 5  شماره 

صفحات  -

تاریخ انتشار 2010